You have searched for "Vaccine"
Showing 61-70 of 4956
HONG KONG (China Daily/ANN): Hong Kong’s economy shrank by 9 per cent in the second quarter from a year earlier as the coronavirus pandemic and social unrest extend the city’s first recession in a decade.
BERLIN (Reuters) - Germany awarded three biotech companies grants to help them speed up the development of coronavirus vaccine candidates, but Research Minister Anja Karliczek said any vaccine was unlikely to be widely available before the middle of next year.
(Reuters) - The British government is confident it can implement measures to ensure spectators can safely return to stadiums amid the COVID-19 pandemic, the country's sports minister has said.
As the demand for domestic travel increases, stakeholders may need to repackage their local products to give them a competitive edge.
JAKARTA (The Jakarta Post/ANN): State-owned pharmaceutical holding company PT Bio Farma is looking for volunteers to assist in the clinical trial of a COVID-19 candidate vaccine developed in partnership with Chinese biopharmaceutical firm Sinovac Biotech, a ministry official has said
BEIJING (Xinhua): China appreciated the remarks of Philippine President Rodrigo Duterte on the South China Sea issue and stood ready to properly resolve maritime disputes with the Philippines through friendly consultations, a Foreign Ministry spokesperson said here on Tuesday (July 28).
The fastest supercomputer in the United States is being put to work in the search for a vaccine to prevent the coronavirus and treat those infected by it.
LONDON: Moderna Inc is planning to price its coronavirus vaccine at US$50 to $60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech, the Financial Times reported on Tuesday, citing unnamed sources
NEW YORK: Wall Street closed lower on Tuesday as investors fretted about weakening consumer confidence, disappointing financial results and as investors worried about wrangling in the U.S. Congress over a coronavirus aid plan.
MOSCOW (Reuters) - A Russian state virology institute has started human trials of the country's second potential COVID-19 vaccine, injecting the first of five volunteers with a dose on July 27, the RIA news agency reported on Tuesday.